REMEMBERING MAYOR THOMAS MENINO: Your Condolences  |  Complete Coverage

Bo Piela

Genzyme headquarters

Genzyme Sold To Sanofi-Aventis In $20 Billion Deal

Cambridge-based biotechnology company Genzyme is being bought by French drug maker Sanofi-Aventis for $20.1 billion, ending months of corporate haggling.



Get every new post delivered to your Inbox.

Join 2,094 other followers